Response to Intravenous N-Acetylcysteine Supplementation in Critically Ill Patients with COVID-19
Yenifer Gamarra-Morales, Lourdes Herrera-Quintana, Jorge Molina-López, Héctor Vázquez-Lorente, Juan Francisco Machado-Casas, José Castaño-Pérez, José Miguel Pérez-Villares, Elena Planells
Nutrients, doi:10.3390/nu15092235
Administering N-acetylcysteine (NAC) could counteract the effect of free radicals, improving the clinical evolution of patients admitted to the Intensive Care Unit (ICU). This study aimed to investigate the clinical and biochemical effects of administering NAC to critically ill patients with COVID-19. A randomized controlled clinical trial was conducted on ICU patients (n = 140) with COVID-19 and divided into two groups: patients treated with NAC (NAC-treated group) and patients without NAC treatment (control group). NAC was administered as a continuous infusion with a loading dose and a maintenance dose during the study period (from admission until the third day of ICU stay). NAC-treated patients showed higher PaO 2 /FiO 2 (p ≤ 0.014) after 3 days in ICU than their control group counterparts. Moreover, C-reactive protein (p ≤ 0.001), D-dimer (p ≤ 0.042), and lactate dehydrogenase (p ≤ 0.001) levels decreased on the third day in NAC-treated patients. Glutathione concentrations decreased in both NAC-treated (p ≤ 0.004) and control (p ≤ 0.047) groups after 3 days in ICU; whereas glutathione peroxidase did not change during the ICU stay. The administration of NAC manages to improve the clinical and analytical response of seriously ill patients with COVID-19 compared to the control group. NAC is able to stop the decrease in glutathione concentrations.
Conflicts of Interest: The authors declare no conflict of interest.
References
Alamdari, Moghaddam, Amini, Keramati, Zarmehri et al., Application of Methylene Blue-Vitamin C-N-Acetyl Cysteine for Treatment of Critically Ill COVID-19 Patients, Eur. J. Pharm,
doi:10.1016/j.ejphar.2020.173494Assimakopoulos, Aretha, Komninos, Dimitropoulou, Lagadinou et al., N-Acetyl-Cysteine Reduces the Risk for Mechanical Ventilation and Mortality in Patients with COVID-19 Pneumonia: A Two-Center Retrospective Cohort Study, Infect. Dis,
doi:10.1080/23744235.2021.1945675Barazzoni, Bischoff, Breda, Wickramasinghe, Krznaric et al., ESPEN Expert Statements and Practical Guidance for Nutritional Management of Individuals with SARS-CoV-2 Infection, Clin. Nutr,
doi:10.1016/j.clnu.2020.03.022Behr, Degenkolb, Krombach, Vogelmeier, Intracellular Glutathione and Bronchoalveolar Cells in Fibrosing Alveolitis: Effects of N-Acetylcysteine, Eur. Respir. J,
doi:10.1183/09031936.02.00204902Bernhard, Junker, Hettinger, Lauterburg, Time Course of Total Cysteine, Glutathione and Homocysteine in Plasma of Patients with Chronic Hepatitis C Treated with Interferon-Alpha with and without Supplementation with N-Acetylcysteine, J. Hepatol,
doi:10.1016/S0168-8278(98)80223-7Borges Do Nascimento, Cacic, Abdulazeem, Von Groote, Jayarajah et al., Novel Coronavirus Infection (COVID-19) in Humans: A Scoping Review and Meta-Analysis, J. Clin. Med,
doi:10.3390/jcm9040941Chen, Wu, Guo, Cao, Huang et al., Clinical and Immunological Features of Severe and Moderate Coronavirus Disease, J. Clin. Investig,
doi:10.1172/JCI137244Darmaun, Smith, Sweeten, Hartman, Welch et al., Poorly Controlled Type 1 Diabetes Is Associated with Altered Glutathione Homeostasis in Adolescents: Apparent Resistance to N-Acetylcysteine Supplementation, Pediatr. Diabetes,
doi:10.1111/j.1399-5448.2008.00436.xDe Alencar, Moreira, Müller, Chaves, Fukuhara et al., Double-Blind, Randomized, Placebo-Controlled Trial With N-Acetylcysteine for Treatment of Severe Acute Respiratory Syndrome Caused by Coronavirus Disease 2019 (COVID-19), Clin. Infect. Dis,
doi:10.1093/cid/ciaa1443De Flora, Balansky, La Maestra, Rationale for the Use of N-Acetylcysteine in Both Prevention and Adjuvant Therapy of COVID-19, FASEB J,
doi:10.1096/fj.202001807Du, Liang, Dong, Lu, Fu et al., Glutathione-Capped Ag2S Nanoclusters Inhibit Coronavirus Proliferation through Blockage of Viral RNA Synthesis and Budding, ACS Appl. Mater. Interfaces,
doi:10.1021/acsami.7b13811Esalatmanesh, Jamali, Esalatmanesh, Soleimani, Khabbazi et al., Effects of N-Acetylcysteine Supplementation on Disease Activity, Oxidative Stress, and Inflammatory and Metabolic Parameters in Rheumatoid Arthritis Patients: A Randomized Double-Blind Placebo-Controlled Trial, Amino Acids,
doi:10.1007/s00726-022-03134-8Fajgenbaum, Langan, Japp, Partridge, Pierson et al., Identifying and Targeting Pathogenic PI3K/AKT/MTOR Signaling in IL-6-Blockade-Refractory Idiopathic Multicentric Castleman Disease, J. Clin. Investig,
doi:10.1172/JCI126091Gamarra, Santiago, Molina-López, Castaño, Herrera-Quintana et al., Pyroglutamic Acidosis by Glutathione Regeneration Blockage in Critical Patients with Septic Shock, Crit. Care,
doi:10.1186/s13054-019-2450-5Gaynitdinova, Avdeev, Merzhoeva, Berikkhanov, Medvedeva et al., N-acetylcysteine as a part of complex treatment of moderate COVID-associated pneumonia, PULMONOLOGIYA,
doi:10.18093/0869-0189-2021-31-1-21-29Geiler, Michaelis, Naczk, Leutz, Langer et al., Inhibits Virus Replication and Expression of pro-Inflammatory Molecules in A549 Cells Infected with Highly Pathogenic H5N1 Influenza A Virus, Biochem. Pharm,
doi:10.1016/j.bcp.2009.08.025Girgis, Baker, Mao, Gil, Javitt et al., Effects of Acute N-Acetylcysteine Challenge on Cortical Glutathione and Glutamate in Schizophrenia: A Pilot in Vivo Proton Magnetic Resonance Spectroscopy Study, Psychiatry Res,
doi:10.1016/j.psychres.2019.03.018Gordon, Jang, Bouhaddou, Xu, Obernier et al., A SARS-CoV-2 Protein Interaction Map Reveals Targets for Drug Repurposing, Nature
Gu, Gong, Zhang, Zheng, Gao et al., Multiple Organ Infection and the Pathogenesis of SARS, J. Exp. Med,
doi:10.1084/jem.20050828Gusdon, Faraday, Aita, Kumar, Mehta et al., Dendrimer Nanotherapy for Severe COVID-19 Attenuates Inflammation and Neurological Injury Markers and Improves Outcomes in a Phase2a Clinical Trial, Sci. Transl. Med,
doi:10.1126/scitranslmed.abo2652Hirai, Jones, Zelt, Da Silva, Bentley et al., Oral N-Acetylcysteine and Exercise Tolerance in Mild Chronic Obstructive Pulmonary Disease, J. Appl. Physiol,
doi:10.1152/japplphysiol.00990.2016Horowitz, Freeman, Bruzzese, Efficacy of Glutathione Therapy in Relieving Dyspnea Associated with COVID-19 Pneumonia: A Report of 2 Cases, Respir. Med. Case Rep,
doi:10.1016/j.rmcr.2020.101063Ibrahim, Perl, Smith, Lewis, Kon et al., Therapeutic Blockade of Inflammation in Severe COVID-19 Infection with Intravenous N-Acetylcysteine, Clin. Immunol,
doi:10.1016/j.clim.2020.108544Ishii, Doi, Okamoto, Imamura, Dohi et al., Neutrophil Elastase Contributes to Acute Lung Injury Induced by Bilateral Nephrectomy, Am. J. Pathol,
doi:10.2353/ajpath.2010.090793Kirchner, Hermann, Möller, Klinger, Solbach et al., Flavonoids and 5-Aminosalicylic Acid Inhibit the Formation of Neutrophil Extracellular Traps, Mediat. Inflamm,
doi:10.1155/2013/710239Lai, Hanczko, Bonilla, Caza, Clair et al., Acetylcysteine Reduces Disease Activity by Blocking Mammalian Target of Rapamycin in T Cells from Systemic Lupus Erythematosus Patients: A Randomized, Double-Blind, Placebo-Controlled Trial,
doi:10.1002/art.34502Liang, Jahraus, Balta, Ziegler, Hübner et al., Sulforaphane Inhibits Inflammatory Responses of Primary Human T-Cells by Increasing ROS and Depleting Glutathione, Front. Immunol
Liu, Wang, Luo, Qian, Wu et al., Experience of N-Acetylcysteine Airway Management in the Successful Treatment of One Case of Critical Condition with COVID-19: A Case Report, Medicine,
doi:10.1097/MD.0000000000022577Madu, Belouzard, Whittaker, SARS-Coronavirus Spike S2 Domain Flanked by Cysteine Residues C822 and C833 Is Important for Activation of Membrane Fusion, Virology,
doi:10.1016/j.virol.2009.07.038Meyer, Buhl, Magnussen, The Effect of Oral N-Acetylcysteine on Lung Glutathione Levels in Idiopathic Pulmonary Fibrosis, Eur. Respir. J,
doi:10.1183/09031936.94.07030431Moradi, Mojtahedzadeh, Mandegari, Soltan-Sharifi, Najafi et al., The Role of Glutathione-S-Transferase Polymorphisms on Clinical Outcome of ALI/ARDS Patient Treated with N-Acetylcysteine, Respir. Med,
doi:10.1016/j.rmed.2008.09.013Pirabbasi, Shahar, Manaf, Rajab, Manap, Efficacy of Ascorbic Acid (Vitamin C) and/N-Acetylcysteine (NAC) Supplementation on Nutritional and Antioxidant Status of Male Chronic Obstructive Pulmonary Disease (COPD) Patients, J. Nutr. Sci. Vitam,
doi:10.3177/jnsv.62.54Polonikov, Endogenous Deficiency of Glutathione as the Most Likely Cause of Serious Manifestations and Death in COVID-19 Patients, ACS Infect. Dis,
doi:10.1021/acsinfecdis.0c00288Porcu, Urbano, Verri, Barbosa, Baracat et al., Effects of Adjunctive N-Acetylcysteine on Depressive Symptoms: Modulation by Baseline High-Sensitivity C-Reactive Protein,
doi:10.1016/j.psychres.2018.02.056Prescott, Illingworth, Critchley, Stewart, Adam et al., Intravenous N-Acetylcystine: The Treatment of Choice for Paracetamol Poisoning, Br. Med. J,
doi:10.1136/bmj.2.6198.1097Qin, Zhou, Hu, Zhang, Yang et al., Dysregulation of Immune Response in Patients With Coronavirus, Clin. Infect. Dis,
doi:10.1093/cid/ciaa248Ruan, Yang, Wang, Jiang, Song, Clinical Predictors of Mortality Due to COVID-19 Based on an Analysis of Data of 150 Patients from Wuhan, China, Intensive Care Med,
doi:10.1007/s00134-020-05991-xRubio, Martin-Mosquero, Ortega, Peces-Barba, González-Mangado, Oral N-Acetylcysteine Attenuates Elastase-Induced Pulmonary Emphysema in Rats, Chest,
doi:10.1378/chest.125.4.1500Rushworth, Megson, Existing and Potential Therapeutic Uses for N-Acetylcysteine: The Need for Conversion to Intracellular Glutathione for Antioxidant Benefits, Pharmacol. Ther,
doi:10.1016/j.pharmthera.2013.09.006Sadowska, Manuel-Y-Keenoy, Vertongen, Schippers, Radomska-Lesniewska et al., Effect of N-Acetylcysteine on Neutrophil Activation Markers in Healthy Volunteers: In Vivo and In Vitro Study, Pharm. Res,
doi:10.1016/j.phrs.2005.11.003Safe, Amaral, Araújo-Pereira, Lacerda, Printes et al., Adjunct N-Acetylcysteine Treatment in Hospitalized Patients with HIV-Associated Tuberculosis Dampens the Oxidative Stress in Peripheral Blood: Results From the RIPENACTB Study Trial,
doi:10.3389/fimmu.2020.602589Schönrich, Raftery, Samstag, Devilishly Radical NETwork in COVID-19: Oxidative Stress, Neutrophil Extracellular Traps (NETs), and T Cell Suppression, Adv. Biol. Regul,
doi:10.1016/j.jbior.2020.100741Seitz, Lerch, Immel, Egbring, D-Dimer, Tests Detect Both Plasmin and Neutrophil Elastase Derived Split Products, Ann. Clin. Biochem,
doi:10.1177/000456329503200211Singer, Blaser, Berger, Alhazzani, Calder et al., ESPEN Guideline on Clinical Nutrition in the Intensive Care Unit, Clin. Nutr,
doi:10.1016/j.clnu.2018.08.037Singh, Schwartz, Disseminated Intravascular Coagulation: A Devastating Systemic Disorder of Special Concern with COVID-19, Dermatol. Ther,
doi:10.1111/dth.14053Soltan-Sharifi, Mojtahedzadeh, Najafi, Reza Khajavi, Reza Rouini et al., Improvement by N-Acetylcysteine of Acute Respiratory Distress Syndrome through Increasing Intracellular Glutathione, and Extracellular Thiol Molecules and Anti-Oxidant Power: Evidence for Underlying Toxicological Mechanisms, Hum. Exp. Toxicol,
doi:10.1177/0960327107083452Szkudlinska, Von Frankenberg, Utzschneider, The Antioxidant N-Acetylcysteine Does Not Improve Glucose Tolerance or β-Cell Function in Type 2 Diabetes, J. Diabetes Complicat,
doi:10.1016/j.jdiacomp.2016.02.003Taher, Lashgari, Sedighi, Rahimi-Bashar, Poorolajal et al., A Pilot Study on Intravenous N-Acetylcysteine Treatment in Patients with Mild-to-Moderate COVID19-Associated Acute Respiratory Distress Syndrome,
doi:10.1007/s43440-021-00296-2Tirouvanziam, Conrad, Bottiglieri, Herzenberg, Moss et al., High-Dose Oral N-Acetylcysteine, a Glutathione Prodrug, Modulates Inflammation in Cystic Fibrosis, Proc. Natl. Acad. Sci,
doi:10.1073/pnas.0511304103Vincent, Moreno, Takala, Willatts, De Mendonça et al., The SOFA (Sepsis-Related Organ Failure Assessment) Score to Describe Organ Dysfunction/Failure. On Behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine, Intensive Care Med,
doi:10.1007/BF01709751Wool, Miller, The Impact of COVID-19 Disease on Platelets and Coagulation, Pathobiology,
doi:10.1159/000512007Xu, Shi, Wang, Zhang, Huang et al., Pathological Findings of COVID-19 Associated with Acute Respiratory Distress Syndrome, Lancet Respir. Med,
doi:10.1016/S2213-2600(20)30076-XZhou, Yu, Du, Fan, Liu et al., Clinical Course and Risk Factors for Mortality of Adult Inpatients with COVID-19 in Wuhan, China: A Retrospective Cohort Study, Lancet
Zuin, Palamidese, Negrin, Catozzo, Scarda et al., High-Dose N-Acetylcysteine in Patients with Exacerbations of Chronic Obstructive Pulmonary Disease, Clin. Drug. Investig,
doi:10.2165/00044011-200525060-00005{ 'indexed': {'date-parts': [[2023, 5, 10]], 'date-time': '2023-05-10T04:42:08Z', 'timestamp': 1683693728855},
'reference-count': 73,
'publisher': 'MDPI AG',
'issue': '9',
'license': [ { 'start': { 'date-parts': [[2023, 5, 8]],
'date-time': '2023-05-08T00:00:00Z',
'timestamp': 1683504000000},
'content-version': 'vor',
'delay-in-days': 0,
'URL': 'https://creativecommons.org/licenses/by/4.0/'}],
'funder': [ {'name': 'Spanish Carlos III Health Institute', 'award': ['FIS PI10/1993']},
{'name': 'Consejería de Educación', 'award': ['REF. A-CTS-708-UGR20']},
{'name': 'Spanish Ministry of Education', 'award': ['REF. FPU18/03702']},
{'name': 'Spanish Ministry of Education', 'award': ['REF. FPU18/03655']}],
'content-domain': {'domain': [], 'crossmark-restriction': False},
'abstract': '<jats:p>Administering N-acetylcysteine (NAC) could counteract the effect of free radicals, '
'improving the clinical evolution of patients admitted to the Intensive Care Unit (ICU). This '
'study aimed to investigate the clinical and biochemical effects of administering NAC to '
'critically ill patients with COVID-19. A randomized controlled clinical trial was conducted '
'on ICU patients (n = 140) with COVID-19 and divided into two groups: patients treated with '
'NAC (NAC-treated group) and patients without NAC treatment (control group). NAC was '
'administered as a continuous infusion with a loading dose and a maintenance dose during the '
'study period (from admission until the third day of ICU stay). NAC-treated patients showed '
'higher PaO2/FiO2 (p ≤ 0.014) after 3 days in ICU than their control group counterparts. '
'Moreover, C-reactive protein (p ≤ 0.001), D-dimer (p ≤ 0.042), and lactate dehydrogenase (p ≤ '
'0.001) levels decreased on the third day in NAC-treated patients. Glutathione concentrations '
'decreased in both NAC-treated (p ≤ 0.004) and control (p ≤ 0.047) groups after 3 days in ICU; '
'whereas glutathione peroxidase did not change during the ICU stay. The administration of NAC '
'manages to improve the clinical and analytical response of seriously ill patients with '
'COVID-19 compared to the control group. NAC is able to stop the decrease in glutathione '
'concentrations.</jats:p>',
'DOI': '10.3390/nu15092235',
'type': 'journal-article',
'created': {'date-parts': [[2023, 5, 9]], 'date-time': '2023-05-09T05:06:28Z', 'timestamp': 1683608788000},
'page': '2235',
'source': 'Crossref',
'is-referenced-by-count': 0,
'title': 'Response to Intravenous N-Acetylcysteine Supplementation in Critically Ill Patients with '
'COVID-19',
'prefix': '10.3390',
'volume': '15',
'author': [ { 'ORCID': 'http://orcid.org/0000-0003-0921-2168',
'authenticated-orcid': False,
'given': 'Yenifer',
'family': 'Gamarra-Morales',
'sequence': 'first',
'affiliation': [ { 'name': 'Clinical Analysis Unit, Valle de los Pedroches Hospital, '
'Pozoblanco, 14400 Córdoba, Spain'}]},
{ 'ORCID': 'http://orcid.org/0000-0003-1407-322X',
'authenticated-orcid': False,
'given': 'Lourdes',
'family': 'Herrera-Quintana',
'sequence': 'additional',
'affiliation': [ { 'name': 'Department of Physiology, School of Pharmacy, Institute of '
'Nutrition and Food Technology “José Mataix”, University of '
'Granada, 18071 Granada, Spain'}]},
{ 'ORCID': 'http://orcid.org/0000-0003-2516-5226',
'authenticated-orcid': False,
'given': 'Jorge',
'family': 'Molina-López',
'sequence': 'additional',
'affiliation': [ { 'name': 'Faculty of Education, Psychology and Sports Sciences, University '
'of Huelva, 21007 Huelva, Spain'}]},
{ 'ORCID': 'http://orcid.org/0000-0003-0183-6902',
'authenticated-orcid': False,
'given': 'Héctor',
'family': 'Vázquez-Lorente',
'sequence': 'additional',
'affiliation': [ { 'name': 'Department of Physiology, School of Pharmacy, Institute of '
'Nutrition and Food Technology “José Mataix”, University of '
'Granada, 18071 Granada, Spain'}]},
{ 'ORCID': 'http://orcid.org/0000-0001-7852-6553',
'authenticated-orcid': False,
'given': 'Juan Francisco',
'family': 'Machado-Casas',
'sequence': 'additional',
'affiliation': [ { 'name': 'Intensive Care Unit, Virgen de las Nieves Hospital, Fuerzas '
'Armadas Avenue, 18014 Granada, Spain'}]},
{ 'given': 'José',
'family': 'Castaño-Pérez',
'sequence': 'additional',
'affiliation': [ { 'name': 'Intensive Care Unit, Virgen de las Nieves Hospital, Fuerzas '
'Armadas Avenue, 18014 Granada, Spain'}]},
{ 'given': 'José Miguel',
'family': 'Pérez-Villares',
'sequence': 'additional',
'affiliation': [ { 'name': 'Intensive Care Unit, Virgen de las Nieves Hospital, Fuerzas '
'Armadas Avenue, 18014 Granada, Spain'}]},
{ 'given': 'Elena',
'family': 'Planells',
'sequence': 'additional',
'affiliation': [ { 'name': 'Department of Physiology, School of Pharmacy, Institute of '
'Nutrition and Food Technology “José Mataix”, University of '
'Granada, 18071 Granada, Spain'}]}],
'member': '1968',
'published-online': {'date-parts': [[2023, 5, 8]]},
'reference': [ { 'key': 'ref_1',
'doi-asserted-by': 'crossref',
'first-page': '75',
'DOI': '10.1111/j.1600-065X.2008.00737.x',
'article-title': 'Innate Immunity to Virus Infection',
'volume': '227',
'author': 'Takeuchi',
'year': '2009',
'journal-title': 'Immunol. Rev.'},
{ 'key': 'ref_2',
'doi-asserted-by': 'crossref',
'first-page': '4410',
'DOI': '10.1128/IAI.72.8.4410-4415.2004',
'article-title': 'Analysis of Serum Cytokines in Patients with Severe Acute Respiratory '
'Syndrome',
'volume': '72',
'author': 'Zhang',
'year': '2004',
'journal-title': 'Infect. Immun.'},
{ 'key': 'ref_3',
'doi-asserted-by': 'crossref',
'first-page': '95',
'DOI': '10.1111/j.1365-2249.2004.02415.x',
'article-title': 'Plasma Inflammatory Cytokines and Chemokines in Severe Acute '
'Respiratory Syndrome',
'volume': '136',
'author': 'Wong',
'year': '2004',
'journal-title': 'Clin. Exp. Immunol.'},
{ 'key': 'ref_4',
'doi-asserted-by': 'crossref',
'first-page': '102',
'DOI': '10.1016/j.jpha.2020.03.001',
'article-title': 'Molecular Immune Pathogenesis and Diagnosis of COVID-19',
'volume': '10',
'author': 'Li',
'year': '2020',
'journal-title': 'J. Pharm. Anal.'},
{ 'key': 'ref_5',
'doi-asserted-by': 'crossref',
'first-page': '3',
'DOI': '10.1016/S0026-0495(00)80077-3',
'article-title': 'What Is Oxidative Stress?',
'volume': '49',
'author': 'Betteridge',
'year': '2000',
'journal-title': 'Metabolism'},
{ 'key': 'ref_6',
'doi-asserted-by': 'crossref',
'first-page': '846',
'DOI': '10.1007/s00134-020-05991-x',
'article-title': 'Clinical Predictors of Mortality Due to COVID-19 Based on an Analysis '
'of Data of 150 Patients from Wuhan, China',
'volume': '46',
'author': 'Ruan',
'year': '2020',
'journal-title': 'Intensive Care Med.'},
{ 'key': 'ref_7',
'doi-asserted-by': 'crossref',
'first-page': '281',
'DOI': '10.1007/s12098-020-03263-6',
'article-title': 'A Review of Coronavirus Disease-2019 (COVID-19)',
'volume': '87',
'author': 'Singhal',
'year': '2020',
'journal-title': 'Indian. J. Pediatr.'},
{ 'key': 'ref_8',
'doi-asserted-by': 'crossref',
'first-page': '415',
'DOI': '10.1084/jem.20050828',
'article-title': 'Multiple Organ Infection and the Pathogenesis of SARS',
'volume': '202',
'author': 'Gu',
'year': '2005',
'journal-title': 'J. Exp. Med.'},
{ 'key': 'ref_9',
'doi-asserted-by': 'crossref',
'first-page': '475',
'DOI': '10.1016/S2213-2600(20)30079-5',
'article-title': 'Clinical Course and Outcomes of Critically Ill Patients with SARS-CoV-2 '
'Pneumonia in Wuhan, China: A Single-Centered, Retrospective, '
'Observational Study',
'volume': '8',
'author': 'Yang',
'year': '2020',
'journal-title': 'Lancet Respir. Med.'},
{ 'key': 'ref_10',
'doi-asserted-by': 'crossref',
'first-page': '1',
'DOI': '10.1016/j.mam.2008.08.006',
'article-title': 'Glutathione: Overview of Its Protective Roles, Measurement, and '
'Biosynthesis',
'volume': '30',
'author': 'Forman',
'year': '2009',
'journal-title': 'Mol. Asp. Med.'},
{ 'key': 'ref_11',
'first-page': '101063',
'article-title': 'Efficacy of Glutathione Therapy in Relieving Dyspnea Associated with '
'COVID-19 Pneumonia: A Report of 2 Cases',
'volume': '30',
'author': 'Horowitz',
'year': '2020',
'journal-title': 'Respir. Med. Case Rep.'},
{ 'key': 'ref_12',
'doi-asserted-by': 'crossref',
'first-page': '1558',
'DOI': '10.1021/acsinfecdis.0c00288',
'article-title': 'Endogenous Deficiency of Glutathione as the Most Likely Cause of '
'Serious Manifestations and Death in COVID-19 Patients',
'volume': '6',
'author': 'Polonikov',
'year': '2020',
'journal-title': 'ACS Infect. Dis.'},
{ 'key': 'ref_13',
'doi-asserted-by': 'crossref',
'first-page': '13185',
'DOI': '10.1096/fj.202001807',
'article-title': 'Rationale for the Use of N-Acetylcysteine in Both Prevention and '
'Adjuvant Therapy of COVID-19',
'volume': '34',
'author': 'Balansky',
'year': '2020',
'journal-title': 'FASEB J.'},
{ 'key': 'ref_14',
'doi-asserted-by': 'crossref',
'first-page': '1054',
'DOI': '10.1016/S0140-6736(20)30566-3',
'article-title': 'Clinical Course and Risk Factors for Mortality of Adult Inpatients with '
'COVID-19 in Wuhan, China: A Retrospective Cohort Study',
'volume': '395',
'author': 'Zhou',
'year': '2020',
'journal-title': 'Lancet'},
{ 'key': 'ref_15',
'doi-asserted-by': 'crossref',
'first-page': '55',
'DOI': '10.1016/j.ejmech.2015.04.040',
'article-title': 'The Role of Antioxidants in the Chemistry of Oxidative Stress: A Review',
'volume': '97',
'author': 'Pisoschi',
'year': '2015',
'journal-title': 'Eur. J. Med. Chem.'},
{ 'key': 'ref_16',
'doi-asserted-by': 'crossref',
'unstructured': 'Borges do Nascimento, I.J., Cacic, N., Abdulazeem, H.M., von Groote, '
'T.C., Jayarajah, U., Weerasekara, I., Esfahani, M.A., Civile, V.T., '
'Marusic, A., and Jeroncic, A. (2020). Novel Coronavirus Infection '
'(COVID-19) in Humans: A Scoping Review and Meta-Analysis. J. Clin. Med., '
'9.',
'DOI': '10.3390/jcm9040941'},
{ 'key': 'ref_17',
'doi-asserted-by': 'crossref',
'first-page': '100741',
'DOI': '10.1016/j.jbior.2020.100741',
'article-title': 'Devilishly Radical NETwork in COVID-19: Oxidative Stress, Neutrophil '
'Extracellular Traps (NETs), and T Cell Suppression',
'volume': '77',
'author': 'Raftery',
'year': '2020',
'journal-title': 'Adv. Biol. Regul.'},
{ 'key': 'ref_18',
'doi-asserted-by': 'crossref',
'first-page': '710239',
'DOI': '10.1155/2013/710239',
'article-title': 'Flavonoids and 5-Aminosalicylic Acid Inhibit the Formation of '
'Neutrophil Extracellular Traps',
'volume': '2013',
'author': 'Kirchner',
'year': '2013',
'journal-title': 'Mediat. Inflamm.'},
{ 'key': 'ref_19',
'doi-asserted-by': 'crossref',
'first-page': '2584',
'DOI': '10.3389/fimmu.2018.02584',
'article-title': 'Sulforaphane Inhibits Inflammatory Responses of Primary Human T-Cells '
'by Increasing ROS and Depleting Glutathione',
'volume': '9',
'author': 'Liang',
'year': '2018',
'journal-title': 'Front. Immunol.'},
{ 'key': 'ref_20',
'doi-asserted-by': 'crossref',
'first-page': '108544',
'DOI': '10.1016/j.clim.2020.108544',
'article-title': 'Therapeutic Blockade of Inflammation in Severe COVID-19 Infection with '
'Intravenous N-Acetylcysteine',
'volume': '219',
'author': 'Ibrahim',
'year': '2020',
'journal-title': 'Clin. Immunol.'},
{ 'key': 'ref_21',
'doi-asserted-by': 'crossref',
'first-page': 'e22577',
'DOI': '10.1097/MD.0000000000022577',
'article-title': 'Experience of N-Acetylcysteine Airway Management in the Successful '
'Treatment of One Case of Critical Condition with COVID-19: A Case '
'Report',
'volume': '99',
'author': 'Liu',
'year': '2020',
'journal-title': 'Medicine (Baltim.)'},
{ 'key': 'ref_22',
'doi-asserted-by': 'crossref',
'first-page': '173494',
'DOI': '10.1016/j.ejphar.2020.173494',
'article-title': 'Application of Methylene Blue-Vitamin C-N-Acetyl Cysteine for Treatment '
'of Critically Ill COVID-19 Patients, Report of a Phase-I Clinical Trial',
'volume': '885',
'author': 'Alamdari',
'year': '2020',
'journal-title': 'Eur. J. Pharm.'},
{ 'key': 'ref_23',
'doi-asserted-by': 'crossref',
'first-page': 'e736',
'DOI': '10.1093/cid/ciaa1443',
'article-title': 'Double-Blind, Randomized, Placebo-Controlled Trial With '
'N-Acetylcysteine for Treatment of Severe Acute Respiratory Syndrome '
'Caused by Coronavirus Disease 2019 (COVID-19)',
'volume': '72',
'author': 'Moreira',
'year': '2021',
'journal-title': 'Clin. Infect. Dis.'},
{ 'key': 'ref_24',
'doi-asserted-by': 'crossref',
'first-page': '1650',
'DOI': '10.1007/s43440-021-00296-2',
'article-title': 'A Pilot Study on Intravenous N-Acetylcysteine Treatment in Patients '
'with Mild-to-Moderate COVID19-Associated Acute Respiratory Distress '
'Syndrome',
'volume': '73',
'author': 'Taher',
'year': '2021',
'journal-title': 'Pharm. Rep.'},
{ 'key': 'ref_25',
'doi-asserted-by': 'crossref',
'unstructured': 'National Health Commission & National Administration of Traditional '
'Chinese Medicine (2020). Diagnosis and treatment protocol for novel '
'coronavirus pneumonia (Trial Version 7). Chin. Med. J., 133, 1087–1095.',
'DOI': '10.1097/CM9.0000000000000819'},
{ 'key': 'ref_26',
'doi-asserted-by': 'crossref',
'unstructured': 'World Medical Association (2013). World Medical Association World '
'Medical Association Declaration of Helsinki: Ethical Principles for '
'Medical Research Involving Human Subjects. JAMA, 310, 2191–2194.',
'DOI': '10.1001/jama.2013.281053'},
{ 'key': 'ref_27',
'doi-asserted-by': 'crossref',
'first-page': '48',
'DOI': '10.1016/j.clnu.2018.08.037',
'article-title': 'ESPEN Guideline on Clinical Nutrition in the Intensive Care Unit',
'volume': '38',
'author': 'Singer',
'year': '2019',
'journal-title': 'Clin. Nutr.'},
{ 'key': 'ref_28',
'doi-asserted-by': 'crossref',
'first-page': '1631',
'DOI': '10.1016/j.clnu.2020.03.022',
'article-title': 'ESPEN Expert Statements and Practical Guidance for Nutritional '
'Management of Individuals with SARS-CoV-2 Infection',
'volume': '39',
'author': 'Barazzoni',
'year': '2020',
'journal-title': 'Clin. Nutr.'},
{ 'key': 'ref_29',
'doi-asserted-by': 'crossref',
'first-page': '1097',
'DOI': '10.1136/bmj.2.6198.1097',
'article-title': 'Intravenous N-Acetylcystine: The Treatment of Choice for Paracetamol '
'Poisoning',
'volume': '2',
'author': 'Prescott',
'year': '1979',
'journal-title': 'Br. Med. J.'},
{ 'key': 'ref_30',
'doi-asserted-by': 'crossref',
'first-page': '818',
'DOI': '10.1097/00003246-198510000-00009',
'article-title': 'APACHE II: A Severity of Disease Classification System',
'volume': '13',
'author': 'Knaus',
'year': '1985',
'journal-title': 'Crit. Care Med.'},
{ 'key': 'ref_31',
'doi-asserted-by': 'crossref',
'first-page': '707',
'DOI': '10.1007/BF01709751',
'article-title': 'The SOFA (Sepsis-Related Organ Failure Assessment) Score to Describe '
'Organ Dysfunction/Failure. On Behalf of the Working Group on '
'Sepsis-Related Problems of the European Society of Intensive Care '
'Medicine',
'volume': '22',
'author': 'Vincent',
'year': '1996',
'journal-title': 'Intensive Care Med.'},
{ 'key': 'ref_32',
'doi-asserted-by': 'crossref',
'first-page': '847',
'DOI': '10.1080/23744235.2021.1945675',
'article-title': 'N-Acetyl-Cysteine Reduces the Risk for Mechanical Ventilation and '
'Mortality in Patients with COVID-19 Pneumonia: A Two-Center '
'Retrospective Cohort Study',
'volume': '53',
'author': 'Assimakopoulos',
'year': '2021',
'journal-title': 'Infect. Dis.'},
{ 'key': 'ref_33',
'doi-asserted-by': 'crossref',
'first-page': '21',
'DOI': '10.18093/0869-0189-2021-31-1-21-29',
'article-title': 'N-acetylcysteine as a part of complex treatment of moderate '
'COVID-associated pneumonia',
'volume': '31',
'author': 'Gaynitdinova',
'year': '2021',
'journal-title': 'PULMONOLOGIYA'},
{ 'key': 'ref_34',
'doi-asserted-by': 'crossref',
'first-page': '2033',
'DOI': '10.1182/blood.2020006000',
'article-title': 'COVID-19 and Its Implications for Thrombosis and Anticoagulation',
'volume': '135',
'author': 'Connors',
'year': '2020',
'journal-title': 'Blood'},
{ 'key': 'ref_35',
'doi-asserted-by': 'crossref',
'first-page': 'e438',
'DOI': '10.1016/S2352-3026(20)30145-9',
'article-title': 'Coagulation Abnormalities and Thrombosis in Patients with COVID-19',
'volume': '7',
'author': 'Levi',
'year': '2020',
'journal-title': 'Lancet Haematol.'},
{ 'key': 'ref_36',
'doi-asserted-by': 'crossref',
'first-page': '1265',
'DOI': '10.1080/17474086.2020.1831383',
'article-title': 'D-Dimer Level in COVID-19 Infection: A Systematic Review',
'volume': '13',
'author': 'Rostami',
'year': '2020',
'journal-title': 'Expert. Rev. Hematol.'},
{ 'key': 'ref_37',
'doi-asserted-by': 'crossref',
'first-page': '15',
'DOI': '10.1159/000512007',
'article-title': 'The Impact of COVID-19 Disease on Platelets and Coagulation',
'volume': '88',
'author': 'Wool',
'year': '2021',
'journal-title': 'Pathobiology'},
{ 'key': 'ref_38',
'doi-asserted-by': 'crossref',
'first-page': '193',
'DOI': '10.1177/000456329503200211',
'article-title': 'D-Dimer Tests Detect Both Plasmin and Neutrophil Elastase Derived Split '
'Products',
'volume': '32',
'author': 'Seitz',
'year': '1995',
'journal-title': 'Ann. Clin. Biochem.'},
{ 'key': 'ref_39',
'doi-asserted-by': 'crossref',
'first-page': '1665',
'DOI': '10.2353/ajpath.2010.090793',
'article-title': 'Neutrophil Elastase Contributes to Acute Lung Injury Induced by '
'Bilateral Nephrectomy',
'volume': '177',
'author': 'Ishii',
'year': '2010',
'journal-title': 'Am. J. Pathol.'},
{ 'key': 'ref_40',
'doi-asserted-by': 'crossref',
'first-page': 'e14053',
'DOI': '10.1111/dth.14053',
'article-title': 'Disseminated Intravascular Coagulation: A Devastating Systemic Disorder '
'of Special Concern with COVID-19',
'volume': '33',
'author': 'Singh',
'year': '2020',
'journal-title': 'Dermatol. Ther.'},
{ 'key': 'ref_41',
'doi-asserted-by': 'crossref',
'first-page': '216',
'DOI': '10.1016/j.phrs.2005.11.003',
'article-title': 'Effect of N-Acetylcysteine on Neutrophil Activation Markers in Healthy '
'Volunteers: In Vivo and In Vitro Study',
'volume': '53',
'author': 'Sadowska',
'year': '2006',
'journal-title': 'Pharm. Res.'},
{ 'key': 'ref_42',
'doi-asserted-by': 'crossref',
'first-page': '4628',
'DOI': '10.1073/pnas.0511304103',
'article-title': 'High-Dose Oral N-Acetylcysteine, a Glutathione Prodrug, Modulates '
'Inflammation in Cystic Fibrosis',
'volume': '103',
'author': 'Tirouvanziam',
'year': '2006',
'journal-title': 'Proc. Natl. Acad. Sci. USA'},
{ 'key': 'ref_43',
'doi-asserted-by': 'crossref',
'first-page': '1500',
'DOI': '10.1378/chest.125.4.1500',
'article-title': 'Oral N-Acetylcysteine Attenuates Elastase-Induced Pulmonary Emphysema '
'in Rats',
'volume': '125',
'author': 'Rubio',
'year': '2004',
'journal-title': 'Chest'},
{ 'key': 'ref_44',
'doi-asserted-by': 'crossref',
'first-page': '4369',
'DOI': '10.1021/acsami.7b13811',
'article-title': 'Glutathione-Capped Ag2S Nanoclusters Inhibit Coronavirus Proliferation '
'through Blockage of Viral RNA Synthesis and Budding',
'volume': '10',
'author': 'Du',
'year': '2018',
'journal-title': 'ACS Appl. Mater. Interfaces'},
{ 'key': 'ref_45',
'doi-asserted-by': 'crossref',
'first-page': '413',
'DOI': '10.1016/j.bcp.2009.08.025',
'article-title': 'N-Acetyl-L-Cysteine (NAC) Inhibits Virus Replication and Expression of '
'pro-Inflammatory Molecules in A549 Cells Infected with Highly '
'Pathogenic H5N1 Influenza A Virus',
'volume': '79',
'author': 'Geiler',
'year': '2010',
'journal-title': 'Biochem. Pharm.'},
{ 'key': 'ref_46',
'doi-asserted-by': 'crossref',
'first-page': '2937',
'DOI': '10.1002/art.34502',
'article-title': 'N-Acetylcysteine Reduces Disease Activity by Blocking Mammalian Target '
'of Rapamycin in T Cells from Systemic Lupus Erythematosus Patients: A '
'Randomized, Double-Blind, Placebo-Controlled Trial',
'volume': '64',
'author': 'Lai',
'year': '2012',
'journal-title': 'Arthritis Rheum.'},
{ 'key': 'ref_47',
'doi-asserted-by': 'crossref',
'first-page': '401',
'DOI': '10.2165/00044011-200525060-00005',
'article-title': 'High-Dose N-Acetylcysteine in Patients with Exacerbations of Chronic '
'Obstructive Pulmonary Disease',
'volume': '25',
'author': 'Zuin',
'year': '2005',
'journal-title': 'Clin. Drug. Investig.'},
{ 'key': 'ref_48',
'doi-asserted-by': 'crossref',
'first-page': '268',
'DOI': '10.1016/j.psychres.2018.02.056',
'article-title': 'Effects of Adjunctive N-Acetylcysteine on Depressive Symptoms: '
'Modulation by Baseline High-Sensitivity C-Reactive Protein',
'volume': '263',
'author': 'Porcu',
'year': '2018',
'journal-title': 'Psychiatry Res.'},
{ 'key': 'ref_49',
'doi-asserted-by': 'crossref',
'first-page': '762',
'DOI': '10.1093/cid/ciaa248',
'article-title': 'Dysregulation of Immune Response in Patients With Coronavirus 2019 '
'(COVID-19) in Wuhan, China',
'volume': '71',
'author': 'Qin',
'year': '2020',
'journal-title': 'Clin. Infect. Dis.'},
{ 'key': 'ref_50',
'doi-asserted-by': 'crossref',
'first-page': '420',
'DOI': '10.1016/S2213-2600(20)30076-X',
'article-title': 'Pathological Findings of COVID-19 Associated with Acute Respiratory '
'Distress Syndrome',
'volume': '8',
'author': 'Xu',
'year': '2020',
'journal-title': 'Lancet Respir. Med.'},
{ 'key': 'ref_51',
'doi-asserted-by': 'crossref',
'first-page': '2620',
'DOI': '10.1172/JCI137244',
'article-title': 'Clinical and Immunological Features of Severe and Moderate Coronavirus '
'Disease 2019',
'volume': '130',
'author': 'Chen',
'year': '2020',
'journal-title': 'J. Clin. Investig.'},
{ 'key': 'ref_52',
'doi-asserted-by': 'crossref',
'first-page': '687',
'DOI': '10.7326/0003-4819-152-10-201005180-00017',
'article-title': 'High-Dose N-Acetylcysteine Therapy for Novel H1N1 Influenza Pneumonia',
'volume': '152',
'author': 'Lai',
'year': '2010',
'journal-title': 'Ann. Intern. Med.'},
{ 'key': 'ref_53',
'doi-asserted-by': 'crossref',
'first-page': '265',
'DOI': '10.1016/j.virol.2009.07.038',
'article-title': 'SARS-Coronavirus Spike S2 Domain Flanked by Cysteine Residues C822 and '
'C833 Is Important for Activation of Membrane Fusion',
'volume': '393',
'author': 'Madu',
'year': '2009',
'journal-title': 'Virology'},
{ 'key': 'ref_54',
'doi-asserted-by': 'crossref',
'first-page': '4451',
'DOI': '10.1172/JCI126091',
'article-title': 'Identifying and Targeting Pathogenic PI3K/AKT/MTOR Signaling in '
'IL-6-Blockade-Refractory Idiopathic Multicentric Castleman Disease',
'volume': '129',
'author': 'Fajgenbaum',
'year': '2019',
'journal-title': 'J. Clin. Investig.'},
{ 'key': 'ref_55',
'doi-asserted-by': 'crossref',
'first-page': '459',
'DOI': '10.1038/s41586-020-2286-9',
'article-title': 'A SARS-CoV-2 Protein Interaction Map Reveals Targets for Drug '
'Repurposing',
'volume': '583',
'author': 'Gordon',
'year': '2020',
'journal-title': 'Nature'},
{ 'key': 'ref_56',
'doi-asserted-by': 'crossref',
'first-page': '162',
'DOI': '10.1186/s13054-019-2450-5',
'article-title': 'Pyroglutamic Acidosis by Glutathione Regeneration Blockage in Critical '
'Patients with Septic Shock',
'volume': '23',
'author': 'Gamarra',
'year': '2019',
'journal-title': 'Crit. Care'},
{ 'key': 'ref_57',
'doi-asserted-by': 'crossref',
'first-page': '19',
'DOI': '10.1016/S0009-8981(03)00200-6',
'article-title': 'Analysis of Glutathione: Implication in Redox and Detoxification',
'volume': '333',
'author': 'Pastore',
'year': '2003',
'journal-title': 'Clin. Chim. Acta'},
{ 'key': 'ref_58',
'doi-asserted-by': 'crossref',
'first-page': '78',
'DOI': '10.1016/j.psychres.2019.03.018',
'article-title': 'Effects of Acute N-Acetylcysteine Challenge on Cortical Glutathione and '
'Glutamate in Schizophrenia: A Pilot in Vivo Proton Magnetic Resonance '
'Spectroscopy Study',
'volume': '275',
'author': 'Girgis',
'year': '2019',
'journal-title': 'Psychiatry Res.'},
{ 'key': 'ref_59',
'doi-asserted-by': 'crossref',
'first-page': '751',
'DOI': '10.1016/S0168-8278(98)80223-7',
'article-title': 'Time Course of Total Cysteine, Glutathione and Homocysteine in Plasma '
'of Patients with Chronic Hepatitis C Treated with Interferon-Alpha with '
'and without Supplementation with N-Acetylcysteine',
'volume': '28',
'author': 'Bernhard',
'year': '1998',
'journal-title': 'J. Hepatol.'},
{ 'key': 'ref_60',
'doi-asserted-by': 'crossref',
'first-page': '577',
'DOI': '10.1111/j.1399-5448.2008.00436.x',
'article-title': 'Poorly Controlled Type 1 Diabetes Is Associated with Altered '
'Glutathione Homeostasis in Adolescents: Apparent Resistance to '
'N-Acetylcysteine Supplementation',
'volume': '9',
'author': 'Darmaun',
'year': '2008',
'journal-title': 'Pediatr. Diabetes'},
{ 'key': 'ref_61',
'doi-asserted-by': 'crossref',
'first-page': '618',
'DOI': '10.1016/j.jdiacomp.2016.02.003',
'article-title': 'The Antioxidant N-Acetylcysteine Does Not Improve Glucose Tolerance or '
'β-Cell Function in Type 2 Diabetes',
'volume': '30',
'author': 'Szkudlinska',
'year': '2016',
'journal-title': 'J. Diabetes Complicat.'},
{ 'key': 'ref_62',
'doi-asserted-by': 'crossref',
'first-page': '54S',
'DOI': '10.1016/0002-9343(91)90284-5',
'article-title': 'N-Acetylcysteine in Experimental and Clinical Acute Lung Injury',
'volume': '91',
'author': 'Bernard',
'year': '1991',
'journal-title': 'Am. J. Med.'},
{ 'key': 'ref_63',
'doi-asserted-by': 'crossref',
'first-page': '697',
'DOI': '10.1177/0960327107083452',
'article-title': 'Improvement by N-Acetylcysteine of Acute Respiratory Distress Syndrome '
'through Increasing Intracellular Glutathione, and Extracellular Thiol '
'Molecules and Anti-Oxidant Power: Evidence for Underlying Toxicological '
'Mechanisms',
'volume': '26',
'author': 'Mojtahedzadeh',
'year': '2007',
'journal-title': 'Hum. Exp. Toxicol.'},
{ 'key': 'ref_64',
'doi-asserted-by': 'crossref',
'first-page': '431',
'DOI': '10.1183/09031936.94.07030431',
'article-title': 'The Effect of Oral N-Acetylcysteine on Lung Glutathione Levels in '
'Idiopathic Pulmonary Fibrosis',
'volume': '7',
'author': 'Meyer',
'year': '1994',
'journal-title': 'Eur. Respir. J.'},
{ 'key': 'ref_65',
'doi-asserted-by': 'crossref',
'first-page': '906',
'DOI': '10.1183/09031936.02.00204902',
'article-title': 'Intracellular Glutathione and Bronchoalveolar Cells in Fibrosing '
'Alveolitis: Effects of N-Acetylcysteine',
'volume': '19',
'author': 'Behr',
'year': '2002',
'journal-title': 'Eur. Respir. J.'},
{ 'key': 'ref_66',
'doi-asserted-by': 'crossref',
'first-page': '915',
'DOI': '10.1046/j.1365-2362.2000.00736.x',
'article-title': 'N-Acetylcysteine Replenishes Glutathione in HIV Infection',
'volume': '30',
'author': 'Zaretsky',
'year': '2000',
'journal-title': 'Eur. J. Clin. Investig.'},
{ 'key': 'ref_67',
'doi-asserted-by': 'crossref',
'first-page': '602589',
'DOI': '10.3389/fimmu.2020.602589',
'article-title': 'Adjunct N-Acetylcysteine Treatment in Hospitalized Patients with '
'HIV-Associated Tuberculosis Dampens the Oxidative Stress in Peripheral '
'Blood: Results From the RIPENACTB Study Trial',
'volume': '11',
'author': 'Safe',
'year': '2020',
'journal-title': 'Front. Immunol.'},
{ 'key': 'ref_68',
'doi-asserted-by': 'crossref',
'first-page': '54',
'DOI': '10.3177/jnsv.62.54',
'article-title': 'Efficacy of Ascorbic Acid (Vitamin C) and/N-Acetylcysteine (NAC) '
'Supplementation on Nutritional and Antioxidant Status of Male Chronic '
'Obstructive Pulmonary Disease (COPD) Patients',
'volume': '62',
'author': 'Pirabbasi',
'year': '2016',
'journal-title': 'J. Nutr. Sci. Vitam.'},
{ 'key': 'ref_69',
'doi-asserted-by': 'crossref',
'first-page': '1351',
'DOI': '10.1152/japplphysiol.00990.2016',
'article-title': 'Oral N-Acetylcysteine and Exercise Tolerance in Mild Chronic '
'Obstructive Pulmonary Disease',
'volume': '122',
'author': 'Hirai',
'year': '2017',
'journal-title': 'J. Appl. Physiol. (1985)'},
{ 'key': 'ref_70',
'doi-asserted-by': 'crossref',
'first-page': '433',
'DOI': '10.1007/s00726-022-03134-8',
'article-title': 'Effects of N-Acetylcysteine Supplementation on Disease Activity, '
'Oxidative Stress, and Inflammatory and Metabolic Parameters in '
'Rheumatoid Arthritis Patients: A Randomized Double-Blind '
'Placebo-Controlled Trial',
'volume': '54',
'author': 'Esalatmanesh',
'year': '2022',
'journal-title': 'Amino Acids'},
{ 'key': 'ref_71',
'doi-asserted-by': 'crossref',
'first-page': '150',
'DOI': '10.1016/j.pharmthera.2013.09.006',
'article-title': 'Existing and Potential Therapeutic Uses for N-Acetylcysteine: The Need '
'for Conversion to Intracellular Glutathione for Antioxidant Benefits',
'volume': '141',
'author': 'Rushworth',
'year': '2014',
'journal-title': 'Pharmacol. Ther.'},
{ 'key': 'ref_72',
'doi-asserted-by': 'crossref',
'first-page': '434',
'DOI': '10.1016/j.rmed.2008.09.013',
'article-title': 'The Role of Glutathione-S-Transferase Polymorphisms on Clinical Outcome '
'of ALI/ARDS Patient Treated with N-Acetylcysteine',
'volume': '103',
'author': 'Moradi',
'year': '2009',
'journal-title': 'Respir. Med.'},
{ 'key': 'ref_73',
'doi-asserted-by': 'crossref',
'first-page': 'eabo2652',
'DOI': '10.1126/scitranslmed.abo2652',
'article-title': 'Dendrimer Nanotherapy for Severe COVID-19 Attenuates Inflammation and '
'Neurological Injury Markers and Improves Outcomes in a Phase2a Clinical '
'Trial',
'volume': '14',
'author': 'Gusdon',
'year': '2022',
'journal-title': 'Sci. Transl. Med.'}],
'container-title': 'Nutrients',
'original-title': [],
'language': 'en',
'link': [ { 'URL': 'https://www.mdpi.com/2072-6643/15/9/2235/pdf',
'content-type': 'unspecified',
'content-version': 'vor',
'intended-application': 'similarity-checking'}],
'deposited': { 'date-parts': [[2023, 5, 9]],
'date-time': '2023-05-09T07:16:55Z',
'timestamp': 1683616615000},
'score': 1,
'resource': {'primary': {'URL': 'https://www.mdpi.com/2072-6643/15/9/2235'}},
'subtitle': [],
'short-title': [],
'issued': {'date-parts': [[2023, 5, 8]]},
'references-count': 73,
'journal-issue': {'issue': '9', 'published-online': {'date-parts': [[2023, 5]]}},
'alternative-id': ['nu15092235'],
'URL': 'http://dx.doi.org/10.3390/nu15092235',
'relation': {},
'ISSN': ['2072-6643'],
'subject': ['Food Science', 'Nutrition and Dietetics'],
'container-title-short': 'Nutrients',
'published': {'date-parts': [[2023, 5, 8]]}}
